Mairi Ziaka, D. Makris, S. Markantonis, E. Zakynthinos
{"title":"长时间脑室内给药奥利斯汀的安全性","authors":"Mairi Ziaka, D. Makris, S. Markantonis, E. Zakynthinos","doi":"10.4172/2314-7326.1000207","DOIUrl":null,"url":null,"abstract":"Mairi Ziaka1, Demosthenes Makris1*, Sophia Markantonis2 and Epaminondas Zakynthinos1 1Critical Care Department, University Hospital of Larissa, Larissa, Greece 2Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Athens, Greece *Corresponding author: Demosthenes Makris, Department of Critical Care Medicine, University Hospital of Larissa,University of Thessaly School of Medicine, Biopolis, Larisa 41000, Greece, Tel: 302413502960; E-mail: dimomakris@med.uth.gr","PeriodicalId":89982,"journal":{"name":"Journal of neuroinfectious diseases","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Safety of Prolonged Intraventricular Administration of Olistin Methanesulphonate\",\"authors\":\"Mairi Ziaka, D. Makris, S. Markantonis, E. Zakynthinos\",\"doi\":\"10.4172/2314-7326.1000207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Mairi Ziaka1, Demosthenes Makris1*, Sophia Markantonis2 and Epaminondas Zakynthinos1 1Critical Care Department, University Hospital of Larissa, Larissa, Greece 2Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Athens, Greece *Corresponding author: Demosthenes Makris, Department of Critical Care Medicine, University Hospital of Larissa,University of Thessaly School of Medicine, Biopolis, Larisa 41000, Greece, Tel: 302413502960; E-mail: dimomakris@med.uth.gr\",\"PeriodicalId\":89982,\"journal\":{\"name\":\"Journal of neuroinfectious diseases\",\"volume\":\"4 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of neuroinfectious diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2314-7326.1000207\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroinfectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2314-7326.1000207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Safety of Prolonged Intraventricular Administration of Olistin Methanesulphonate
Mairi Ziaka1, Demosthenes Makris1*, Sophia Markantonis2 and Epaminondas Zakynthinos1 1Critical Care Department, University Hospital of Larissa, Larissa, Greece 2Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Athens, Greece *Corresponding author: Demosthenes Makris, Department of Critical Care Medicine, University Hospital of Larissa,University of Thessaly School of Medicine, Biopolis, Larisa 41000, Greece, Tel: 302413502960; E-mail: dimomakris@med.uth.gr